Analyst firms · Piper Sandler · ARDX

Piper Sandler ARDX price target and rating history

Ardelyx Inc. (ARDX) · Health Care

Piper Sandler rates Ardelyx Inc. (ARDX) Overweight with a $7 price target, as of its latest action on Jan 9, 2026. It has published 4 rating actions on ARDX since July 2021, including 2 upgrades and 2 downgrades.

Current rating
Overweight
Price target
$7
Median target, all firms
Too few
Actions on ARDX
4

Piper Sandler price target on ARDX

$8$6$420222023202420252026
Piper Sandler price target on ARDX, each point a stated target, July 2021 to July 2024.

Every Piper Sandler rating on ARDX

How other firms rate ARDX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Ladenburg ThalmannBuy$16Jun 16, 2026
Piper SandlerOverweightJan 9, 2026

Questions about Piper Sandler and ARDX

What is Piper Sandler's price target for ARDX?
Piper Sandler's latest stated price target for Ardelyx Inc. (ARDX) is $7, from its action on Jul 2, 2024.
What is Piper Sandler's rating on ARDX?
Piper Sandler rates ARDX Overweight, a bullish rating, as of Jan 9, 2026.
When did Piper Sandler last change its view on ARDX?
On Jan 9, 2026, Piper Sandler upgrades to Overweight from Neutral.

More ARDX rating histories

All Piper Sandler ratingsARDX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.